Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RANDOMIZED CONTROLLED TRIAL OF THE USE OF TEXT MESSAGE REMINDERS TO INCREASE PNEUMOCOCCAL VACCINATION COVERAGE IN ADULTS AGED 65 YEARS IN CHILE.

NCT07659470 is registered in ClinicalTrials.gov with Pablo Tomás Valenzuela García as lead sponsor.

NCT NCT07659470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07659470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RANDOMIZED CONTROLLED TRIAL OF THE USE OF TEXT MESSAGE REMINDERS TO INCREASE PNEUMOCOCCAL VACCINATION COVERAGE IN ADULTS AGED 65 YEARS IN CHILE.
Lead sponsor
Pablo Tomás Valenzuela García
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 15, 2026
Completion date
October 1, 2026
Enrollment
43,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aged 65 years or older, health promotion, immunization programs, pneumococcal infections, reminder systems, text messaging (intervention), vaccination coverage